Showing results (81-90 of 283) with videos related to
Sort By:
Pageof 29
Theriogenology|June 18, 2015
Coat and claws as new matrices for noninvasive long-term cortisol assessment in dogs from birth up to 30 days of ageM C Veronesi, A Comin, T Meloni, et al.British Medical Journal|November 1, 1980
Pituitary responsiveness to gonadotrophin-releasing and thyrotrophin-releasing hormones in children receiving phenobarbitoneA Masala, T Meloni, S Alagna, et al.Theriogenology|December 10, 2014
Immunoglobulins G and lysozyme concentrations in canine fetal fluids at term of pregnancyP Dall'Ara, T Meloni, A Rota, et al.Haematologica|November 1, 1995
Clonazepam prophylaxis and busulfan-related myoclonic epilepsy in autografted acute leukemia patientsG Meloni, L Nasta, R M Pinto, et al.Leukemia|February 1, 1989
Phase II trial of intermediate dose ARA-C (IDAC) with sequential mitoxantrone (MITOX) in acute myelogenous leukemiaS Amadori, G Meloni, M C Petti, et al.European Journal of Haematology|May 1, 1989
Acute myelogenous leukemia in first relapse treated with two consecutive autologous bone marrow transplantations: a pilot studyG Meloni, P De Fabritis, A Pulsoni, et al.Leukemia & Lymphoma|July 28, 2016
Induction and Persistence of Complete Remission in a Resistant Acute Myeloid Leukemia Patient after Treatment with Recombinant Interleukin-2R Foà, M T Fierro, S Tosti, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1992
Pretransplant conditioning with busulfan and cyclophosphamide in acute leukemia patients: neurological and electroencephalographic prospective studyG Meloni, U Raucci, R M Pinto, et al.Haematologica|July 1, 1996
Lack of efficacy of a double autograft program to prolong survival of chronic myelogenous leukemia patients in blastic transformationS Capria, M Vignetti, E Montefusco, et al.The Journal of Biological Chemistry|October 4, 1996
Localization of the effector-specifying regions of Gi2alpha and GqalphaR Medina, G Grishina, E G Meloni, et al.Pageof 29